Black Diamond Therapeutics Inc. (BDTX): Price and Financial Metrics
BDTX Price/Volume Stats
| Current price | $2.20 | 52-week high | $7.66 |
| Prev. close | $2.21 | 52-week low | $1.91 |
| Day low | $2.11 | Volume | 930,700 |
| Day high | $2.25 | Avg. volume | 1,777,109 |
| 50-day MA | $2.48 | Dividend yield | N/A |
| 200-day MA | $4.42 | Market Cap | 124.49M |
BDTX Stock Price Chart Interactive Chart >
Black Diamond Therapeutics Inc. (BDTX) Company Bio
Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
BDTX Price Returns
| 1-mo | -0.90% |
| 3-mo | -28.10% |
| 6-mo | -64.69% |
| 1-year | -17.60% |
| 3-year | -42.71% |
| 5-year | N/A |
| YTD | 2.80% |
| 2024 | -23.84% |
| 2023 | 56.11% |
| 2022 | -66.23% |
| 2021 | -83.37% |
| 2020 | N/A |
Loading social stream, please wait...